Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Accolade, Inc. - common stock (NQ: ACCD )

4.030 -0.180 (-4.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Accolade, Inc. - common stock

< Previous 1 2 3 4 5 6 7 Next >
Apple To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower! 
Via InvestorPlace
ACCD Stock Earnings: Accolade Beats EPS, Beats Revenue for Q1 2025
ACCD stock results show that Accolade beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025. 
Via InvestorPlace
Accolade Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
A Glimpse Into The Expert Outlook On Accolade Through 7 Analysts
Via Benzinga
Accolade: Q3 Earnings Insights
Via Benzinga
Accolade Stock Tumbles On Q1 Earnings, Weak Guidance: What You Need To Know
Accolade Inc shares are tanking in Thursday's after-hours session after the company reported financial results for its fiscal first quarter and issued weak guidance. 
Via Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The popular growth investor bought into one of Thursday's biggest losers and two stocks that have fallen sharply over the past year. 
Via The Motley Fool
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
ACCD Stock Earnings: Accolade Misses EPS, Beats Revenue for Q4 2024
ACCD stock results show that Accolade missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
A Preview Of Accolade's Earnings
Via Benzinga
Expert Ratings for Accolade
Via Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Alabama’s Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers
The recent Alabama State Supreme Court ruling on frozen embryos could have national repercussions. Here's what you need to know about it. 
Via InvestorPlace
Nasdaq Edges Higher; Cutera Shares Jump
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.53% to 37,484.13 while the NASDAQ rose 0.15% to 14,866.50. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Gains Over 2%; TD SYNNEX Posts Downbeat Sales
U.S. stocks traded mostly lower midway through trading, with the Dow Jones falling around 180 points on Tuesday. The Dow traded down 0.49% to 37,499.41 while the NASDAQ rose 0.07% to 14,853.45. The S&P... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session. 
Via Benzinga
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Healthcare Technology Company Accolade Shares Are Surging Today
Accolade Inc (NASDAQ: ACCD) shares are trading higher after the company announced  
Via Benzinga
ACCD Stock Earnings: Accolade Beats EPS, Beats Revenue for Q3 2024
ACCD stock results show that Accolade beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For January 8, 2024
Companies Reporting Before The Bell • Helen Of Troy (NASDAQ:HELE) is likely to report quarterly earnings at $2.75 per share on revenue of $544.39 million. 
Via Benzinga
Cathie Wood's Ark Invest Trims Bitcoin Exposure, Sells $2.9M Worth Of GBTC Shares Amid Crypto Market Volatility
On Thursday, Cathie Wood-led Ark Invest made a significant move by selling nearly $2.9 million worth of Grayscale Bitcoin Trust (OTC:GBTC) shares. This decision comes amidst a fluctuating crypto market... 
Via Benzinga
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter... 
Via Benzinga
Topics Stocks
Exposures US Equities
1 Market-Beating Stock to Buy Near Its 52-Week High
This stock has been firing on all cylinders -- and it isn't about to stop. 
Via The Motley Fool
Alignment Healthcare's Valuation Shows Promise In A Competitive Market: Analyst
Alignment Healthcare Inc (NASDAQ: ALHC) announced that its California Medicare Advantage (MA) HMO – which represents roughly 89% of its MA membership – has maintained an overall 4 out of 5-star rating... 
Via Benzinga
Obesity Medication Insurance Coverage? Employers Embrace the Inclusion of Novo Nordisk's Wegovy in Health Coverage
Coverage for obesity medications, including Novo Nordisk A/S's (NYSE: NVO) Wegovy, is expected to expand among U.S. 
Via Benzinga
Why Eli Lilly Stock Crawled Higher Today
The pharmaceutical giant gets a lift from some good news on insurance coverage and a prognosticator's price-target lift. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.